BioSpace News Archive

Summer is the perfect time for picnics and barbecues. During these outdoor gatherings, it’s important to keep food safety in mind.

Researchers from Children’s Hospital of Philadelphia and the University of Pennsylvania found that lesbian, gay and bisexual youth experienced more interpersonal discrimination based on others perceiving them as lesbian, gay, or bisexual and were four times more likely to attempt suicide.

Merit Medical Systems, Inc. announced that it will release its financial results for the quarter ended June 30, 2023, after the close of the stock market on Tuesday, July 25, 2023.

Astria Therapeutics, Inc., a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, granted stock options to purchase 60,000 shares of Astria’s common stock on July 3, 2023 under Astria’s 2022 Inducement Stock Incentive Plan.

[06-July-2023] SINGAPORE , July 6, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor cell-based immunotherapies for the treatment of various cancers, announce that the CAR-gamma delta T cell (CAR-γδ T cell) technology, which it has

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has purchased the Blink ® product line of eye and contact lens drops from Johnson & Johnson Vision.

IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announced a strategic investment from four investment funds managed by Bradbury Asset Management (Hong Kong) Limited (“Bradbury”) who is a leading asset management firm with over $2 billion in managed assets.

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT) today announced the signing of a strategic platform license (SPL) with Lyell Immunopharma, Inc., a clinical stage T cell reprogramming company.

Genesis MedTech announced that its ArtiSential™, a revolutionary series of articulating laparoscopic instruments, has successfully obtained approval from the China’s National Medical Products Administration for market release.

ProQR Therapeutics NV. today announced a presentation at the RNA Editing Summit, July 11-13, 2023 in Boston, MA, USA.